Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection

被引:39
作者
Baptista, T
de Baptista, EA
Lalonde, J
Plamondon, J
Kin, NMKNY
Beaulieu, S
Joober, R
Richard, D
机构
[1] Univ Los Andes, Sch Med, Dept Physiol, Merida 5101 A, Venezuela
[2] McGill Univ, Douglas Hosp, Res Ctr, Verdun, PQ H4H 1R3, Canada
[3] Univ Los Andes, Sch Pharm, Merida, Venezuela
[4] Univ Laval, Sch Med, Quebec City, PQ G1K 7P4, Canada
关键词
antipsychotic drugs; obesity; macronutrient intake; animal model; hyperthropic obesity; hyperplasic obesity;
D O I
10.1016/j.pnpbp.2004.08.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Previous studies showed that the antipsychotic drugs (APDs) sulpiride (SUL) and risperidone (R-IS) induced body weight gain (BWG), hyperphagia, and increased serum levels of leptin, prolactin and corticosterone in female rats. Neither SUL nor RIS increased BWG or food intake (FI) in male rats. To further develop the animal model of APD-induced obesity. SUL (20 mg/kg/sc), RIS (0.5 mg/kg/sc) or vehicle (1 cm(3)/kg/sc) were administered to female Wistar rats for 10 or 12 days. Body composition. fat tissue morphology, energy expenditure and food efficiency were assessed in animals fed a high-fat diet. In another experiment, macronutrient selection was evaluated in animals fed with pure diets. SUL and RIS significantly increased BWG and FI, with a stronger effect of SUL. Both drugs increased fat gain and food efficiency and did not modify energy expenditure. Obesity was due to adipocyte hyperplasia. SUL-treated rats significantly decreased fat intake (p=0-039), showed a tendency to increase protein intake and did not modify carbohydrate consumption. No differences were observed between the RIS and the vehicle group. The macronutrient selection pattern differs from that observed in obese people undergoing APD treatment and in most animal models of obesity. Those findings suggest that SUL administration does not properly model APD treatment in humans. Results on macronutient selection in RIS-treated rats must be considered as preliminary since in this experiment the animals did not pin weigh; significantly. Other diet protocols and lower APD doses must be tested to further characterize the RIS model. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1305 / 1311
页数:7
相关论文
共 48 条
[1]  
Allison DB, 1999, AM J PSYCHIAT, V156, P1686
[2]   An animal model of antipsychotic-induced weight gain [J].
Arjona, AA ;
Zhang, SX ;
Adamson, B ;
Wurtman, RJ .
BEHAVIOURAL BRAIN RESEARCH, 2004, 152 (01) :121-127
[3]   Obesity and related metabolic abnormalities during antipsychotic drug administration: Mechanisms, management and research perspectives [J].
Baptista, T ;
Kin, NMKNY ;
Beaulieu, S ;
de Baptista, EA .
PHARMACOPSYCHIATRY, 2002, 35 (06) :205-219
[4]   Drug induced weight gain, an impediment to successful pharmacotherapy:: Focus on antipsychotics [J].
Baptista, T ;
Zárate, J ;
Joober, R ;
Colasante, C ;
Beaulieu, S ;
Páez, X ;
Hernández, L .
CURRENT DRUG TARGETS, 2004, 5 (03) :279-299
[5]   Comparative effects of the antipsychotics sulpiride or risperidone in rats - I: Bodyweight, food intake, body composition, hormones and glucose tolerance [J].
Baptista, T ;
de Baptista, EA ;
Kin, NMKNY ;
Beaulieu, S ;
Walker, D ;
Joober, R ;
Lalonde, J ;
Richard, D .
BRAIN RESEARCH, 2002, 957 (01) :144-151
[6]   The antipsychotic drug sulpiride does not affect bodyweight in male rats.: Is insulin resistance involved? [J].
Baptista, T ;
Lacruz, A ;
Pàez, X ;
Hernàndez, L ;
Beaulieu, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 447 (01) :91-98
[7]   SYSTEMIC SULPIRIDE INCREASES DOPAMINE METABOLITES IN THE LATERAL HYPOTHALAMUS [J].
BAPTISTA, T ;
HERNANDEZ, L ;
HOEBEL, BG .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 37 (02) :227-229
[8]   Antipsychotic drugs and obesity:: Is prolactin involved? [J].
Baptista, T ;
Lacruz, A ;
Meza, T ;
Contreras, Q ;
Delgado, C ;
Mejìas, MA ;
Hernàndez, L .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2001, 46 (09) :829-834
[9]   EFFECTS OF LONG-TERM ADMINISTRATION OF CLOZAPINE ON BODY-WEIGHT AND FOOD-INTAKE IN RATS [J].
BAPTISTA, T ;
MATA, A ;
TENEUD, L ;
DEQUIJADA, M ;
HAN, HW ;
HERNANDEZ, L .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, 45 (01) :51-54
[10]   Glucose tolerance and serum insulin levels in an animal model of obesity induced by sub-acute or chronic administration of antipsychotic drugs [J].
Baptista, T ;
Alvarez, L ;
Lacruz, A ;
De Mendoza, S ;
Hernández, L .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1999, 23 (02) :277-287